Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Vetgruppen Brønderslev Dyrehospital ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   12.9% 11.2% 9.5% 7.6% 8.3% 5.4% 13.0% 13.0%   Credit score (0-100)   19 23 26 31 29 41 18 18   Credit rating   BB BB BB BB BB BBB BB BB   Credit limit (kDKK)   -0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,118 2,807 3,300 3,499 3,658 3,989 0.0 0.0   EBITDA   -218 282 450 227 103 -275 0.0 0.0   EBIT   -364 133 281 39.3 -1.5 -439 0.0 0.0   Pre-tax profit (PTP)   -425.8 113.8 271.7 32.9 -15.0 -537.5 0.0 0.0   Net earnings   -360.9 113.8 271.7 184.4 -231.4 -531.9 0.0 0.0   Pre-tax profit without non-rec. items   -426 114 272 32.9 -15.0 -537 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   415 385 248 284 578 443 0.0 0.0   Shareholders equity total   -701 -587 -315 -131 -362 1,106 1,054 1,054   Interest-bearing liabilities   990 505 0.0 0.0 1,050 1,345 0.0 0.0   Balance sheet total (assets)   939 932 1,602 1,386 1,618 3,487 1,054 1,054   Net Debt   971 484 -415 -446 756 854 -1,054 -1,054     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,118 2,807 3,300 3,499 3,658 3,989 0.0 0.0   Gross profit growth   33.8% 32.5% 17.6% 6.0% 4.5% 9.0% -100.0% 0.0%   Employees   5 5 7 8 8 11 0 0   Employee growth %   0.0% 0.0% 40.0% 14.3% 0.0% 37.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   939 932 1,602 1,386 1,618 3,487 1,054 1,054   Balance sheet change%   -14.2% -0.7% 71.9% -13.4% 16.7% 115.5% -69.8% 0.0%   Added value   -217.8 282.0 449.5 226.5 185.7 -275.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -293 -194 -320 -166 176 -313 -443 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 3.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -17.2% 4.7% 8.5% 1.1% -0.0% -11.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -19.8% 8.4% 16.4% 2.3% -0.1% -15.9% 0.0% 0.0%   ROI %   -28.8% 16.9% 72.5% 41.4% -0.3% -24.8% 0.0% 0.0%   ROE %   -35.5% 12.2% 21.4% 12.3% -15.4% -39.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -42.7% -38.6% -16.5% -8.6% -18.3% 31.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -445.6% 171.7% -92.3% -196.9% 737.0% -310.2% 0.0% 0.0%   Gearing %   -141.2% -86.0% 0.0% 0.0% -289.8% 121.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.8% 2.6% 3.7% 0.0% 2.6% 8.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 0.1 0.5 0.6 0.2 0.3 0.0 0.0   Current Ratio   0.3 0.3 0.8 0.8 0.4 0.4 0.0 0.0   Cash and cash equivalent   19.1 20.6 415.0 446.0 293.5 490.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,197.4 -958.8 -425.8 -259.2 -1,057.2 -1,251.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -44 56 64 28 23 -25 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -44 56 64 28 13 -25 0 0   EBIT / employee   -73 27 40 5 -0 -40 0 0   Net earnings / employee   -72 23 39 23 -29 -48 0 0